Morgan Stanley analyst Terence Flynn maintained a Buy rating on Legend Biotech yesterday and set a price target of $83.00. The company’s shares ...
Morgan Stanley analyst Terence Flynn maintained a Buy rating on Legend Biotech yesterday and set a price target of $83.00. The company’s shares ...